Asad Loya

ORCID: 0000-0002-2136-4650
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nonmelanoma Skin Cancer Studies
  • Ocular Oncology and Treatments
  • Cutaneous Melanoma Detection and Management
  • Retinal Diseases and Treatments
  • Glaucoma and retinal disorders
  • Cancer and Skin Lesions
  • Sarcoma Diagnosis and Treatment
  • Retinal Imaging and Analysis
  • Multiple and Secondary Primary Cancers
  • Diversity and Career in Medicine
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Diabetes Treatment and Management
  • Infectious Diseases and Mycology
  • Cancer Diagnosis and Treatment
  • Retinal and Optic Conditions
  • Management of metastatic bone disease
  • Ear and Head Tumors
  • Economic and Financial Impacts of Cancer
  • Healthcare Systems and Technology
  • Intraocular Surgery and Lenses
  • Cutaneous lymphoproliferative disorders research
  • Traumatic Ocular and Foreign Body Injuries
  • Vascular Tumors and Angiosarcomas
  • Bartonella species infections research
  • Neurosurgical Procedures and Complications

Baylor College of Medicine
2019-2025

Novartis (Switzerland)
2023

AbbVie (United States)
2023

Regeneron (United States)
2023

EyePoint Pharmaceuticals (United States)
2023

Apellis Pharmaceuticals (United States)
2023

Baylor School
2021

University of Houston
2020

The University of Texas Medical Branch at Galveston
2019-2020

Liverpool Hospital
2020

Loneliness is a well-established risk factor for poor physical health. Much less known about how loneliness affects patient-reported outcomes (PROs), such as somatic symptoms, which are increasingly important guiding symptom management and assessing quality of patient care. The current study investigates whether (a) social isolation predict cold symptoms independent each other, (b) more robust than objective experiencing symptoms.

10.1037/hea0000467 article EN other-oa Health Psychology 2017-03-30

Abstract Background With the rising incidence of melanoma in situ ( MIS ) or cutaneous melanoma, there is an increasing emphasis on need to understand optimal treatment strategies. The current standard surgical care wide local excision WLE ). Alternative techniques have been proposed including Mohs micrographic surgery MMS We aimed compare survival rates following versus for . Methods performed a retrospective analysis Surveillance, Epidemiology, and End Results SEER cancer registry. 24,515...

10.1111/ijd.14374 article EN International Journal of Dermatology 2019-01-03

Background: Various surgical options can be used to remove melanoma in situ (MIS). These include wide local excision (WLE), staged excision, and Mohs micrographic surgery (MMS). For MIS lesions located the head neck regions, WLE approach may not always a technically feasible option if both cosmesis anatomical function is preserved.Methods: We performed retrospective analysis of Surveillance, Epidemiology, End Results (SEERs) cancer registry. A total 7933 cases region were included this...

10.1080/09546634.2019.1639605 article EN Journal of Dermatological Treatment 2019-07-02

10.1016/j.jaapos.2022.11.014 article EN Journal of American Association for Pediatric Ophthalmology and Strabismus 2023-01-05

To investigate the association between early lifetime substance use on development of severe visual acuity impairment or blindness a national level.National Survey Drug Use and Health data was used to identify cases before 21* years age, within past year, self-reported impairment. Univariable multivariable binary logistic regression with time-dependency performed evaluate odds influenced by 16 substances separated into three classes: prescription, non-prescription, illicit drugs. Adjusted...

10.2147/opth.s401167 article EN cc-by-nc Clinical ophthalmology 2023-03-01

Evaluate incidence of second primary malignancies (SPM) after non-acral cutaneous melanoma (NACM), acral lentiginous (ALM), mucosal (MM), and uveal (UM).First NACM, ALM, MM, UM cases diagnosed 2000-2016 were extracted from SEER. Seer*Stat was used to calculate excess absolute risks (EAR) standardized ratios (SIR) SPMs relative a matched cohort the general population. P-value 0.05 determined significance.Inclusion criteria met by 109,385 patients with 2166 2498 6250 UM. Increased occurred...

10.3389/fonc.2022.853076 article EN cc-by Frontiers in Oncology 2022-03-18

An ocular or periocular malignancy can profoundly impact patients' lives as they cope with the challenges of a potentially life-threatening diagnosis and exhaustive treatment process it entails. amalgam biopsychosocial factors influence prognosis. This study aims to determine whether marital status impacts long-term survival patients these malignancies.A retrospective analysis Surveillance, Epidemiology, End Results (SEER) database was performed. Patients malignancies diagnosed between 1973...

10.2147/opth.s238034 article EN cc-by-nc Clinical ophthalmology 2020-04-01

Abstract Background Although studies have investigated the risk of second primary malignancies (SPMs) associated with lymphoma various sites, limited this in patients originating within ocular adnexa. We conducted a retrospective study to assess incidence secondary prior diagnosis adnexal (OAL) and determine latency periods age-groups at increased for SPM occurrence. Methods Retrospective analysis was performed on data obtained from Surveillance, Epidemiology, End Results (SEER) 9 database....

10.1186/s12886-021-01921-7 article EN cc-by BMC Ophthalmology 2021-04-07

Background: The prevalence of idiopathic intracranial hypertension (IIH) is rising with the global obesity epidemic. Carbonic anhydrase inhibitors (CAIs), such as acetazolamide, have been shown to be effective in IIH but can also lead kidney stone formation. This study evaluates risk development patients treated CAIs. Methods: A retrospective cohort using TriNetX database was performed compare CAIs vs. untreated controls. Propensity score matching (PSM) balanced demographic and clinical...

10.1097/wno.0000000000002307 article EN Journal of Neuro-Ophthalmology 2024-12-27
Coming Soon ...